rs16960959

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016239.4(MYO15A):​c.7468G>A​(p.Ala2490Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00665 in 1,601,094 control chromosomes in the GnomAD database, including 605 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 354 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 251 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.471

Publications

8 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001448214).
BP6
Variant 17-18150908-G-A is Benign according to our data. Variant chr17-18150908-G-A is described in ClinVar as Benign. ClinVar VariationId is 45759.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.7468G>A p.Ala2490Thr missense_variant Exon 38 of 66 ENST00000647165.2 NP_057323.3 Q9UKN7-1
MYO15AXM_017024715.3 linkc.7471G>A p.Ala2491Thr missense_variant Exon 36 of 64 XP_016880204.1
MYO15AXM_017024714.3 linkc.7408G>A p.Ala2470Thr missense_variant Exon 35 of 63 XP_016880203.1
LOC124903944XR_007065652.1 linkn.377+695C>T intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.7468G>A p.Ala2490Thr missense_variant Exon 38 of 66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1

Frequencies

GnomAD3 genomes
AF:
0.0359
AC:
5466
AN:
152120
Hom.:
354
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000559
Gnomad OTH
AF:
0.0230
GnomAD2 exomes
AF:
0.00907
AC:
2040
AN:
224928
AF XY:
0.00697
show subpopulations
Gnomad AFR exome
AF:
0.127
Gnomad AMR exome
AF:
0.00759
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000619
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000499
Gnomad OTH exome
AF:
0.00451
GnomAD4 exome
AF:
0.00356
AC:
5163
AN:
1448856
Hom.:
251
Cov.:
33
AF XY:
0.00309
AC XY:
2223
AN XY:
719742
show subpopulations
African (AFR)
AF:
0.120
AC:
3995
AN:
33176
American (AMR)
AF:
0.00847
AC:
360
AN:
42478
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25868
East Asian (EAS)
AF:
0.0000256
AC:
1
AN:
39092
South Asian (SAS)
AF:
0.000236
AC:
20
AN:
84820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52188
Middle Eastern (MID)
AF:
0.00373
AC:
19
AN:
5098
European-Non Finnish (NFE)
AF:
0.000290
AC:
321
AN:
1106216
Other (OTH)
AF:
0.00746
AC:
447
AN:
59920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
343
686
1028
1371
1714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0360
AC:
5478
AN:
152238
Hom.:
354
Cov.:
32
AF XY:
0.0342
AC XY:
2548
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.124
AC:
5147
AN:
41522
American (AMR)
AF:
0.0157
AC:
240
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000559
AC:
38
AN:
68000
Other (OTH)
AF:
0.0227
AC:
48
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
241
482
723
964
1205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00789
Hom.:
123
Bravo
AF:
0.0402
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.112
AC:
453
ESP6500EA
AF:
0.00120
AC:
10
ExAC
AF:
0.0106
AC:
1275
Asia WGS
AF:
0.00635
AC:
23
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala2490Thr in Exon 38 of MYO15A: This variant is not expected to have clinical s ignificance because it has been identified in 11.0% (370/3368) of African Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs16960959). -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 3 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
11
DANN
Benign
0.92
DEOGEN2
Benign
0.0072
T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.44
T;.;T
MetaRNN
Benign
0.0014
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
.;N;N
PhyloP100
0.47
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.69
.;N;.
REVEL
Benign
0.23
Sift
Benign
0.15
.;T;.
Sift4G
Benign
0.53
T;T;.
Polyphen
0.0
.;B;B
Vest4
0.024
ClinPred
0.00073
T
GERP RS
-0.71
Varity_R
0.037
gMVP
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16960959; hg19: chr17-18054222; API